SARS-CoV-2 Vaccine (ImmunoPrecise Antibodies)

N/A

Report date: 2024/09/05 17:00:51

Base Information

Drug NameSARS-CoV-2 Vaccine (ImmunoPrecise Antibodies)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmunoPrecise Antibodies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLiteVax BVImmunoPrecise Antibodies Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeJ07BX
Related LinksN/A